LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article: A Precision Medicine Approach to Rhinitis Evaluation and Management.

    Crisci, Carlos D / Ardusso, Ledit R F

    Current treatment options in allergy

    2020  Volume 7, Issue 1, Page(s) 93–109

    Abstract: Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. The PM approach focuses on the characterization of different phenotypes and pathogenic pathways in order to allow the selection of ... ...

    Abstract Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. The PM approach focuses on the characterization of different phenotypes and pathogenic pathways in order to allow the selection of specific biomarkers that will be useful in disease management. Rhinitis is a highly prevalent and heterogeneous disease, both in terms of underlying endotypes and clinical presentations. Therefore, to apply the PM principles to the various rhinitis subtypes rise as a meaningful strategy to improve evaluation and treatment.
    Recent findings: The technology of recombinant allergens has allowed molecular characterization of IgE reactivity of specific individual components of allergenic extracts. Recently published and ongoing clinical trials based on component resolved diagnosis (CRD) bring more precision to allergen immunotherapy for allergic rhinitis. Monoclonal antibodies against various cytokines involved in inflammatory allergic and nonallergic rhinitis endotypes show promissory results.
    Summary: Better understanding of pathogenic pathways together with an accurate phenotype classification of patients presented with rhinitis symptoms contributes to point out clinical usefulness of biomarkers and other diagnostic tools, which leads to more accurate environmental control measures, personalized pharmacologic options, and new biological therapy developments.
    Keywords covid19
    Language English
    Publishing date 2020-02-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ISSN 2196-3053
    ISSN 2196-3053
    DOI 10.1007/s40521-020-00243-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.

    Crisci, Carlos D / Ardusso, Ledit R F / Mossuz, Antonela / Müller, Leila

    Current treatment options in allergy

    2020  Volume 7, Issue 3, Page(s) 422–440

    Abstract: Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. To apply PM premises in an emerging coronavirus pandemic acquires potentially greater relevance in order to allow the selection of ... ...

    Abstract Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. To apply PM premises in an emerging coronavirus pandemic acquires potentially greater relevance in order to allow the selection of specific preventive measures as well as biomarkers that will be useful in disease management.
    Recent findings: The identification of the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the responsible for the coronavirus disease 2019 (COVID-19) pandemic had led to a plethora of strategies to contain viral dissemination, affecting life styles and personal behaviors. Viral genomic sequencing has shown that SARS-CoV-2 spike protein utilizes angiotensin-converting enzyme 2 (ACE2) found on ciliated epithelial cells of the human lungs as its specific receptor. Neutralizing antibodies to the receptor-binding domain of the spike protein were detected in patients recovered from COVID-19; however, both T cells and NK cells were reduced in severe cases. Excessive and uncontrolled releases of pro-inflammatory cytokines such as IL-1B, IL-1RA, IL-7, IL-8, IL-9, IL-10, fibroblast growth factor (FGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor (TNFα) were increased in severe patients. These cytokines might be useful biomarkers of disease worsening and potential targets for new biological therapies currently under investigation.
    Summary: Present knowledge and recent developments in PM approach to COVID-19 disease prevention, evaluation, and management are pointed out. Better understanding of pathogenic pathways together with an accurate phenotype classification of patients presented with SARS-CoV-2 infection and symptoms might contribute to a more accurate definition of biomarkers and other diagnostic tools, which may lead to more precise mitigation strategies, personalized pharmacologic options, as well as new biological therapy developments.
    Keywords covid19
    Language English
    Publishing date 2020-05-08
    Publishing country Switzerland
    Document type Journal Article ; Review
    ISSN 2196-3053
    ISSN 2196-3053
    DOI 10.1007/s40521-020-00258-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A Precision Medicine Approach to SARS-CoV-2 Pandemic Management

    Crisci, Carlos D. / Ardusso, Ledit R. F. / Mossuz, Antonela / Müller, Leila

    Current Treatment Options in Allergy

    2020  Volume 7, Issue 3, Page(s) 422–440

    Keywords covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ISSN 2196-3053
    DOI 10.1007/s40521-020-00258-8
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article: A Precision Medicine Approach to SARS-CoV-2 Pandemic Management

    Crisci, Carlos D / Ardusso, Ledit R F / Mossuz, Antonela / Müller, Leila

    Curr Treat Options Allergy

    Abstract: Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. To apply PM premises in an emerging coronavirus pandemic acquires potentially greater relevance in order to allow the selection of ... ...

    Abstract Purpose of review: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. To apply PM premises in an emerging coronavirus pandemic acquires potentially greater relevance in order to allow the selection of specific preventive measures as well as biomarkers that will be useful in disease management. Recent findings: The identification of the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the responsible for the coronavirus disease 2019 (COVID-19) pandemic had led to a plethora of strategies to contain viral dissemination, affecting life styles and personal behaviors. Viral genomic sequencing has shown that SARS-CoV-2 spike protein utilizes angiotensin-converting enzyme 2 (ACE2) found on ciliated epithelial cells of the human lungs as its specific receptor. Neutralizing antibodies to the receptor-binding domain of the spike protein were detected in patients recovered from COVID-19; however, both T cells and NK cells were reduced in severe cases. Excessive and uncontrolled releases of pro-inflammatory cytokines such as IL-1B, IL-1RA, IL-7, IL-8, IL-9, IL-10, fibroblast growth factor (FGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor (TNFα) were increased in severe patients. These cytokines might be useful biomarkers of disease worsening and potential targets for new biological therapies currently under investigation. Summary: Present knowledge and recent developments in PM approach to COVID-19 disease prevention, evaluation, and management are pointed out. Better understanding of pathogenic pathways together with an accurate phenotype classification of patients presented with SARS-CoV-2 infection and symptoms might contribute to a more accurate definition of biomarkers and other diagnostic tools, which may lead to more precise mitigation strategies, personalized pharmacologic options, as well as new biological therapy developments.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #197704
    Database COVID19

    Kategorien

  5. Article ; Online: La Red de Telesalud de las Américas y su papel en la atención primaria de la salud.

    Bill, Guillermo / Crisci, Carlos D / Canet, Tomislav

    Revista panamericana de salud publica = Pan American journal of public health

    2014  Volume 35, Issue 5-6, Page(s) 442–445

    Abstract: The need to guarantee equitable access to health regardless of geographic, economic, or technological barriers motivated the Member States of the Organization of American States to create the Telehealth Network of the Americas, coordinated by the Inter- ... ...

    Title translation The Telehealth Network of the Americas and its role in primary health care.
    Abstract The need to guarantee equitable access to health regardless of geographic, economic, or technological barriers motivated the Member States of the Organization of American States to create the Telehealth Network of the Americas, coordinated by the Inter-American Telecommunication Committee. The Network focuses on the use of new information and communications technology applied to health, based on the values of respect, equity, and solidarity and mandated by the philosophy of primary health. Its members include government agencies, nongovernmental organizations, university forums, hospital federations, and telecommunications companies, and it has already extended its reach to other continents and to different fields in which telemedicine is being used. Among its first achievements, it has implemented an innovative tool to be used in cases of disaster or limited geographic access. This mobile telemedicine station is housed in a portable case that includes a computer, various digital devices (otoscope, ophthalmoscope, microscope, dermatoscope), a high-resolution digital camera, an X-ray film viewer, and a satellite antenna. With this tool, it is possible to provide specialized support for rural physicians and primary health care workers located far from large urban centers.
    MeSH term(s) Americas ; Humans ; Medical Informatics ; Primary Health Care ; Telemedicine/organization & administration
    Language Spanish
    Publishing date 2014-09-10
    Publishing country United States
    Document type English Abstract ; Journal Article
    ZDB-ID 1376934-0
    ISSN 1680-5348 ; 1020-4989
    ISSN (online) 1680-5348
    ISSN 1020-4989
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book ; Article ; Online: La Red de Telesalud de las Américas y su papel en la atención primaria de la salud

    Bill, Guillermo / Crisci, Carlos D. / Canet, Tomislav

    2015  

    Keywords Telecomunicaciones ; Telemedicina ; Proyectos de Tecnologías de Información y Comunicación ; Telecommunications ; Telemedicine ; Information technologies and communication projects
    Publishing date 2015-08-25T14:52:17Z
    Document type Book ; Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: La Red de Telesalud de las Américas y su papel en la atención primaria de la salud

    Guillermo Bill / Carlos D. Crisci / Tomislav Canet

    Revista Panamericana de Salud Pública, Vol 35, Iss 5-6, Pp 442-

    2014  Volume 445

    Abstract: La necesidad de garantizar un acceso equitativo a la salud, con independencia de las limitaciones geográficas, económicas y tecnológicas, motivó a los estados miembros de la Organización de Estados Americanos a impulsar la creación de una Red de ... ...

    Abstract La necesidad de garantizar un acceso equitativo a la salud, con independencia de las limitaciones geográficas, económicas y tecnológicas, motivó a los estados miembros de la Organización de Estados Americanos a impulsar la creación de una Red de Telesalud de las Américas (Red TSA) dependiente de la Comisión Interamericana de Telecomunicaciones. La Red TSA es un desarrollo centrado en el uso de las nuevas tecnologías de la información y la comunicación aplicadas a la salud, asentado en valores de respeto, equidad y solidaridad y amparado en la filosofía de la atención primaria de la salud e integrado por instituciones gubernamentales y no gubernamentales, foros de universidades, federaciones hospitalarias y empresas de telecomunicaciones, y ha iniciado su difusión en diferentes ámbitos continentales y mundiales relacionados con la telemedicina. Entre sus primeros logros, ha puesto en marcha una novedosa herramienta de aplicación en situaciones de catástrofes y escasa accesibilidad geográfica (estación de telemedicina móvil), consistente en un maletín portátil compuesto por un ordenador, diferentes dispositivos digitales (otoscopio, oftalmoscopio, microscopio y dermatoscopio), cámara digital de alta resolución, negatoscopio y antena de conexión satelital. Este maletín permite dar apoyo especializado a los médicos rurales y locales de atención primaria de la salud alejados de los grandes centros urbanos.
    Keywords Telecomunicaciones ; telemedicina ; proyectos de tecnologías de información y la comunicación ; Medicine ; R ; Arctic medicine. Tropical medicine ; RC955-962 ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2014-06-01T00:00:00Z
    Publisher Pan American Health Organization
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Assessment of the 90-day mortality risk score after video-assisted thoracoscopic lobectomy in the Italian VATS Group cohort.

    Imperatori, Andrea / Cattoni, Maria / Bertolaccini, Luca / Nosotti, Mario / Rosso, Lorenzo / Cagini, Lucio / Vannucci, Jacopo / Brunelli, Alessandro / Crisci, Roberto / Curcio, Carlo / Rotolo, Nicola

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2023  

    Abstract: ... and class A to E. Hosmer-Lemeshow chi-squared value was 67.47 (p<0.001) with overall, Class D and E ...

    Abstract A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), DLCO <60% (1 point) and operative time >150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, to confirm its generalizability. From the Italian VATS Group Database, we selected 2,209 patients [60% males; median age 69 years (IQR:63-74)] who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's r-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test. Class A-E 90-day mortality rates were 0.33%, 0.51%, 1.39%, 1.31% and 2.56%, respectively. A strong uphill correlation was identified between risk classes and 90-day mortality (r=0.90; p=0.037), showing a positive correlation between increased mortality rate and class A to E. Hosmer-Lemeshow chi-squared value was 67.47 (p<0.001) with overall, Class D and E significantly lower 90-day mortality in our cohort than in the original one [1.04% vs 2.5% (p=0.018), 1.31% vs 5.65% (p=0.005) and 2.56% vs 18.75% (p=0.007), respectively]. Despite our data show a positive correlation between 90-day mortality and risk classes from A to E with modest discriminatory performance, the poor calibration suggests the need for model recalibration using local data to better manage and counsel lung cancer patients eligible for video-assisted thoracoscopic lobectomy.
    Language English
    Publishing date 2023-07-28
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2023.2569
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Is It Possible to Establish a Reliable Correlation between Maximum Standardized Uptake Value of 18-Fluorine Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Histological Types of Non-Small Cell Lung Cancer? Analysis of the Italian VATS Group Database.

    Divisi, Duilio / Rinaldi, Marta / Necozione, Stefano / Curcio, Carlo / Rea, Federico / Zaraca, Francesco / De Vico, Andrea / Zaccagna, Gino / Di Leonardo, Gabriella / Crisci, Roberto / On Behalf Of The Italian Vats Group

    Diagnostics (Basel, Switzerland)

    2021  Volume 11, Issue 10

    Abstract: ... deoxy-2-[fluorine-18] fluorine-D-glucose (18F-FDG-PET/CT), is fundamental in the assessment ... for invasive adenocarcinoma; and (d) 8.85 ± 6.70 for squamous cell carcinoma. Processing ...

    Abstract Background: Although positron emission tomography/computed tomography, often integrated with 2-deoxy-2-[fluorine-18] fluorine-D-glucose (18F-FDG-PET/CT), is fundamental in the assessment of lung cancer, the relationship between metabolic avidity of different histotypes and maximum standardized uptake value (SUVmax) has not yet been thoroughly investigated. The aim of the study is to establish a reliable correlation between Suvmax and histology in non-small cell lung cancer (NSCLC), in order to facilitate patient management.
    Methods: We retrospectively assessed the data about lung cancer patients entered in the Italian Registry of VATS Group from January 2014 to October 2019, after establishing the eligibility criteria of the study. In total, 8139 patients undergoing VATS lobectomy were enrolled: 3260 females and 4879 males. The relationship between SUVmax and tumor size was also analyzed.
    Results: The mean values of SUVmax in the most frequent types of lung cancer were as follows: (a) 4.88 ± 3.82 for preinvasive adenocarcinoma; (b) 5.49 ± 4.10 for minimally invasive adenocarcinoma; (c) 5.87 ± 4.18 for invasive adenocarcinoma; and (d) 8.85 ± 6.70 for squamous cell carcinoma. Processing these data, we displayed a statistically difference (
    Conclusions: There is a correlation between SUVmax, histopathology outcomes and tumor size in NSCLC. Further clinical trials should be performed in order to confirm our data.
    Language English
    Publishing date 2021-10-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics11101901
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy

    Caterina Claudia Lepre / Marina Russo / Maria Consiglia Trotta / Francesco Petrillo / Fabiana Anna D’Agostino / Gennaro Gaudino / Giovanbattista D’Amico / Maria Rosaria Campitiello / Erminia Crisci / Maddalena Nicoletti / Carlo Gesualdo / Francesca Simonelli / Michele D’Amico / Anca Hermenean / Settimio Rossi

    International Journal of Molecular Sciences, Vol 24, Iss 9721, p

    2023  Volume 9721

    Abstract: Diabetic retinopathy (DR) is the most frequent microvascular retinal complication of diabetic patients, contributing to loss of vision. Recently, retinal neuroinflammation and neurodegeneration have emerged as key players in DR progression, and therefore, ...

    Abstract Diabetic retinopathy (DR) is the most frequent microvascular retinal complication of diabetic patients, contributing to loss of vision. Recently, retinal neuroinflammation and neurodegeneration have emerged as key players in DR progression, and therefore, this review examines the neuroinflammatory molecular basis of DR. We focus on four important aspects of retinal neuroinflammation: (i) the exacerbation of endoplasmic reticulum (ER) stress; (ii) the activation of the NLRP3 inflammasome; (iii) the role of galectins; and (iv) the activation of purinergic 2X7 receptor (P2X7R). Moreover, this review proposes the selective inhibition of galectins and the P2X7R as a potential pharmacological approach to prevent the progression of DR.
    Keywords diabetic retinopathy ; neuroinflammation ; ROS ; ER stress ; NLRP3 inflammasome ; galectins ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top